Search

Your search keyword '"Vandenhende M."' showing total 155 results

Search Constraints

Start Over You searched for: Author "Vandenhende M." Remove constraint Author: "Vandenhende M."
155 results on '"Vandenhende M."'

Search Results

1. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

5. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

8. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

11. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH)

12. Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France

14. Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH)

15. Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB)

19. Gender differences in the use of cardiovascular interventions in HIV?positive persons; the D:A:D Study

20. Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission

21. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

23. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)

24. Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection

26. Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB).

28. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)

29. Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

31. Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older

34. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

35. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

38. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

39. TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality

42. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

43. Ecological diagnosis of the Palus de Molua hydrosystems: Project of Nature Reserve in Hourtin

44. pH, part1. pH measurement good practice

45. STP PHARMA PRATIQUES Micropipettes Partie I. Bonnes pratiques de pipetage

Catalog

Books, media, physical & digital resources